Biopharamceutical

Shares of AbbVie Inc (NYSE: ABBV) were trading lower by more than 4 percent early Friday morning after the company reported its fourth quarter results. AbbVie earned $1.13 per share in the fourth quarter on revenue of $6.36 billion. Wall Street analysts were expecting the company to earn $1.12...

Shares of XenoPort, Inc. (NASDAQ: XNPT) were trading higher by nearly 6 percent at $5.07 early Friday morning. Reuters reported late Thursday afternoon that the bio-pharmaceutical company is in the early stages of exploring a potential sale of itself. Citing "people familiar with the...